CTD-ILD
Rheumatoid arthritis
Spondyloarthritis
Saliva diagnostics
Biomarker discovery
Date | Time | Room | Session Title | Lecture Title |
---|---|---|---|---|
May 21 | 08:00-08:40 | Room B | [Breakfast Symposium V - Lilly] Ixekizumab: Recent Updates on the Treatment of Spondyloarthritis | IL-17 inhibition in spondyloarthritis: The efficacy of Ixekizumab and clinical relevance |